Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis

Front Immunol. 2023 Jul 14:14:1148595. doi: 10.3389/fimmu.2023.1148595. eCollection 2023.

Abstract

Introduction: The Coronavirus Disease 2019 (COVID-19) is mainly a respiratory syndrome that can affect multiple organ systems, causing a variety of symptoms. Among the most common and characteristic symptoms are deficits in smell and taste perception, which may last for weeks/months after COVID-19 diagnosis owing to mechanisms that are not fully elucidated.

Methods: In order to identify the determinants of olfactory symptom persistence, we obtained olfactory mucosa (OM) from 21 subjects, grouped according to clinical criteria: i) with persistent olfactory symptoms; ii) with transient olfactory symptoms; iii) without olfactory symptoms; and iv) non-COVID-19 controls. Cells from the olfactory mucosa were harvested for transcriptome analyses.

Results and discussion: RNA-Seq assays showed that gene expression levels are altered for a long time after infection. The expression profile of micro RNAs appeared significantly altered after infection, but no relationship with olfactory symptoms was found. On the other hand, patients with persistent olfactory deficits displayed increased levels of expression of genes involved in the inflammatory response and zinc homeostasis, suggesting an association with persistent or transient olfactory deficits in individuals who experienced SARS-CoV-2 infection.

Keywords: RNA-seq; SARS-CoV-2; inflammation; metallothionein; miRNA; olfactory symptoms; zinc homeostasis.

MeSH terms

  • Adult
  • Aged
  • COVID-19* / complications
  • COVID-19* / immunology
  • Female
  • Gene Expression Profiling
  • Homeostasis*
  • Humans
  • Inflammation*
  • Male
  • Middle Aged
  • Olfaction Disorders* / etiology
  • Olfaction Disorders* / virology
  • Olfactory Mucosa* / metabolism
  • Olfactory Mucosa* / virology
  • SARS-CoV-2* / physiology
  • Smell
  • Transcriptome
  • Zinc* / metabolism

Substances

  • Zinc

Grants and funding

This work has been supported by Grant COVID-CNS (to AA) of Cassa di Risparmio di Padova e Rovigo (CARIPARO); Grant DOR from the University of Padova (CM), PARO_FINA20_01 (to CP), PRIN 2020LW7XWH (to AG) and the Promega Corporation 2019 Real-Time PCR Grant program (to ABi).